44.81
price up icon1.70%   0.75
after-market Dopo l'orario di chiusura: 45.02 0.21 +0.47%
loading

Exelixis Inc Borsa (EXEL) Ultime notizie

pulisher
03:22 AM

Exelixis Insiders Sell US$12m Of Stock, Possibly Signalling Caution - simplywall.st

03:22 AM
pulisher
Jul 15, 2025

Long Term Trading Analysis for (EXEL) - news.stocktradersdaily.com

Jul 15, 2025
pulisher
Jul 15, 2025

Will Exelixis (EXEL) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

Jul 15, 2025
pulisher
Jul 15, 2025

Truist Securities raises Exelixis stock price target to $56 on positive outlook - Investing.com Canada

Jul 15, 2025
pulisher
Jul 15, 2025

Truist Lifts Price Target on Exelixis to $56 From $55, Keeps Buy Rating - MarketScreener

Jul 15, 2025
pulisher
Jul 14, 2025

Exelixis to Release Second Quarter 2025 Financial Results on Monday, July 28, 2025 - BioSpace

Jul 14, 2025
pulisher
Jul 14, 2025

Press Release: Exelixis to Release Second Quarter 2025 Financial Results on Monday, July 28, 2025 - 富途牛牛

Jul 14, 2025
pulisher
Jul 14, 2025

Exelixis (EXEL) is an Incredible Growth Stock: 3 Reasons Why - sharewise.com

Jul 14, 2025
pulisher
Jul 12, 2025

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT) and Exelixis (EXEL) - The Globe and Mail

Jul 12, 2025
pulisher
Jul 11, 2025

Barclays Remains a Hold on Exelixis (EXEL) - The Globe and Mail

Jul 11, 2025
pulisher
Jul 10, 2025

Assessing Exelixis: Insights From 12 Financial Analysts - Nasdaq

Jul 10, 2025
pulisher
Jul 08, 2025

RBC Capital Keeps Their Buy Rating on Exelixis (EXEL) - The Globe and Mail

Jul 08, 2025
pulisher
Jul 08, 2025

Exelixis cut to sector perform at RBC as cash flows fairly valued - Seeking Alpha

Jul 08, 2025
pulisher
Jul 08, 2025

RBC Downgrades Exelixis to Sector Perform From Outperform, Lifts Price Target to $50 From $45 - MarketScreener

Jul 08, 2025
pulisher
Jul 08, 2025

Exelixis (EXEL): Why Now is the Time to Act on Strong Clinical and Financial Catalysts - AInvest

Jul 08, 2025
pulisher
Jul 08, 2025

Exelixis: I Was Wrong To Be Too Cautious (Rating Upgrade) - Seeking Alpha

Jul 08, 2025
pulisher
Jul 07, 2025

Exelixis Surges 35.2% in Three Months: Buy or Sell the Stock? - The Globe and Mail

Jul 07, 2025
pulisher
Jul 07, 2025

Why Exelixis (EXEL) is a Top Growth Stock for the Long-Term - Yahoo Finance

Jul 07, 2025
pulisher
Jul 07, 2025

Exelixis’s SWOT analysis: stock poised for growth amid pipeline progress - Investing.com

Jul 07, 2025
pulisher
Jul 03, 2025

Zacks Industry Outlook Highlights Exelixis, Verona Pharma, Alkermes, Kiniska Pharmaceuticals and Immunocore - Yahoo Finance

Jul 03, 2025
pulisher
Jul 02, 2025

Cancer index outperforms broader markets with 13% Q2 rebound - BioWorld MedTech

Jul 02, 2025
pulisher
Jun 30, 2025

Exelixis, Inc. (EXEL) Stock Analysis: Riding the Wave of 30.60% Revenue Growth in the Biotechnology Sphere - DirectorsTalk Interviews

Jun 30, 2025
pulisher
Jun 30, 2025

Zacks.com featured highlights include Exelixis, Lyft and Kinross Gold - Yahoo Finance

Jun 30, 2025
pulisher
Jun 26, 2025

Stephens Upgrades Exelixis (EXEL) Stock, Raises PT - Insider Monkey

Jun 26, 2025
pulisher
Jun 25, 2025

Exelixis (EXEL) Surges 7.4%: Is This an Indication of Further Gains? - MSN

Jun 25, 2025
pulisher
Jun 25, 2025

The Zacks Analyst Blog Highlights Sprouts Farmers Market, Royal Gold, Thomson Reuters, Woodward and Exelixis - The Globe and Mail

Jun 25, 2025
pulisher
Jun 24, 2025

Stifel Nicolaus Sticks to Its Hold Rating for Exelixis (EXEL) - The Globe and Mail

Jun 24, 2025
pulisher
Jun 23, 2025

Truist Raises Price Target on Exelixis to $55 From $43, Keeps Buy Rating - MarketScreener

Jun 23, 2025
pulisher
Jun 22, 2025

Exelixis' Zanzalintinib: A Breakthrough in Colorectal Cancer and a Catalyst for Growth - AInvest

Jun 22, 2025
pulisher
Jun 20, 2025

Exelixis (EXEL) Awaits EU Decision on CABOMETYX Approval | EXEL Stock News - GuruFocus

Jun 20, 2025
pulisher
Jun 19, 2025

Those who invested in Exelixis (NASDAQ:EXEL) three years ago are up 102% - Yahoo Finance

Jun 19, 2025
pulisher
Jun 18, 2025

Here's Why Exelixis (EXEL) is a Strong Value Stock - Yahoo Finance

Jun 18, 2025
pulisher
Jun 14, 2025

How to Take Advantage of moves in (EXEL) - news.stocktradersdaily.com

Jun 14, 2025
pulisher
Jun 14, 2025

Exelixis’s SWOT analysis: cabozantinib’s strength, zanzalintinib’s potential drive stock outlook - Investing.com Canada

Jun 14, 2025
pulisher
Jun 13, 2025

Zacks.com featured highlights include Flex, CVS Health, Urban Outfitters and Exelixis - Yahoo Finance

Jun 13, 2025
pulisher
Jun 12, 2025

EXEL: HC Wainwright & Co. Raises Price Target to $47.00 | EXEL S - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Exelixis stock maintains buy rating at H.C. Wainwright on promising data - Investing.com Canada

Jun 12, 2025
pulisher
Jun 12, 2025

Why Is Exelixis (EXEL) Down 7.2% Since Last Earnings Report? - Yahoo Finance

Jun 12, 2025
pulisher
Jun 12, 2025

Exelixis, Inc.'s (NASDAQ:EXEL) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - simplywall.st

Jun 12, 2025
pulisher
Jun 12, 2025

EXEL: HC Wainwright & Co. Raises Price Target to $47.00 | EXEL Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Exelixis (EXEL) Stock Target Boosted by H.C. Wainwright | EXEL S - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Promising Clinical Data and Favorable Safety Profile Drive Buy Rating for Exelixis - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Exelixis (EXEL) Stock Target Boosted by H.C. Wainwright | EXEL Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 10, 2025

Indexes Rise But Growth Plays Hit; Quanta Services, Exelixis, Google In Focus - Investor's Business Daily

Jun 10, 2025
pulisher
Jun 09, 2025

Kalkine: Exelixis Joins Momentum Wave Ahead of Russell 1000 Rebalance - Kalkine Media

Jun 09, 2025
pulisher
Jun 09, 2025

BofA Hikes Exelixis, Inc. (EXEL) Target Amid CRC Caution - MSN

Jun 09, 2025
pulisher
Jun 09, 2025

3 Reasons Why Growth Investors Shouldn't Overlook Exelixis (EXEL) - Yahoo Finance

Jun 09, 2025
pulisher
Jun 09, 2025

Exelixis, Inc. (EXEL) Stock Analysis: A Biotech Powerhouse with Robust Revenue Growth - DirectorsTalk Interviews

Jun 09, 2025
pulisher
Jun 09, 2025

Exelixis, Inc. (NASDAQ:EXEL) Stock Holdings Increased by GAMMA Investing LLC - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Bank of America Forecasts Strong Price Appreciation for Exelixis (NASDAQ:EXEL) Stock - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

Brokerages Set Exelixis, Inc. (NASDAQ:EXEL) Price Target at $38.94 - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

Zacks Research Has Bullish Forecast for Exelixis Q2 Earnings - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Exelixis Escapes Cancer Drug Invalidity Bid At PTAB - Law360

Jun 06, 2025
pulisher
Jun 06, 2025

Are You Looking for a Top Momentum Pick? Why Exelixis (EXEL) is a Great Choice - Yahoo Finance

Jun 06, 2025
pulisher
Jun 05, 2025

Analyst Expectations For Exelixis's Future - Benzinga

Jun 05, 2025
pulisher
Jun 05, 2025

Exelixis (EXEL) Sees Price Target Raised by B of A Securities | - GuruFocus

Jun 05, 2025
$21.87
price up icon 3.40%
$35.60
price down icon 2.49%
$104.59
price up icon 1.67%
$28.27
price up icon 16.05%
$112.49
price up icon 1.66%
biotechnology ONC
$279.16
price up icon 3.51%
Capitalizzazione:     |  Volume (24 ore):